Shore Health Systems

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Examen para fibrosis quística neonatal - Risks

Nombres alternativos

Tripsinógeno inmunorreactivo; Prueba IRT; Examen para fibrosis quística en neonatos

Riesgos:

Los riesgos asociados con el examen son, entre otros:

  • Infección (un riesgo leve en cualquier momento que se presente ruptura de la piel)
  • Ansiedad con relación a los resultados falsos positivos
  • Confianza falsa con relación a resultados falsos negativos

Consideraciones:

Los resultados del examen no revelan la gravedad de la fibrosis quística y se pueden presentar resultados falsos positivos.
  • Reviewed last on: 6/1/2011
  • Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

Referencias

Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic fibrosis consensus report. Pediatrics. Aug 2008;153(2).

Boat TF, Acton JD. Cystic fibrosis. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 400.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com